1. Metabolic Enzyme/Protease
  2. Phospholipase


Phospholipase is a member of a very complex group of enzymes that break down phospholipids into fatty acids and other compounds. Phospholipases are defined by the enzymatic reaction they catalyze. The classes are phospholipase A, which has members A1 and A2; phospholipase B, which can carry out the reactions of both A1 and A2; phospholipase C; and phospholipase D.

Phospholipase A2 (PLA2) catalyses the hydrolysis of the sn-2 position of glycerophospholipids to yield fatty acids and lysophospholipids. Phospholipase C (PLC) converts phosphatidylinositol 4,5-bisphosphate (PIP2) to inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). DAG and IP3 each control diverse cellular processes and are also substrates for synthesis of other important signaling molecules. PLC is thus central to many important interlocking regulatory networks. Phospholipase D (PLD) is an essential enzyme responsible for the production of the lipid second messenger phosphatidic acid (PA), which is involved in fundamental cellular processes, including membrane trafficking, actin cytoskeleton remodeling, cell proliferation and cell survival.

Phospholipase Related Products (19):

Cat. No. Product Name Effect Purity
  • HY-13419
    U-73122 Inhibitor
    U-73122 is an inhibitor of phospholipase C (PLC), phospholipase A2, and 5-LO (5-lipoxygenase)
  • HY-70072
    D609 Inhibitor >98.0%
    D609 is a selective competitive inhibitor of phosphatidyl choline-specific phospholipase C (PC-PLC), with Ki of 6.4 μM, used for antiviral and antitumor research.
  • HY-13402
    Varespladib Inhibitor 98.75%
    LY315920 (Varespladib) is a potent and selective human non-pancreatic secretory phospholipase A2 (sPLA) inhibitor with IC50 of 7 nM.
  • HY-12807
    FIPI Inhibitor 99.53%
    FIPI is a derivative of halopemide which potently inhibits both PLD1 and PLD2 with IC50s of 25 nM and 20 nM, respectively.
  • HY-10521
    Darapladib Inhibitor 99.95%
    Darapladib is a potent inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2) with IC50 of 0.25 nM.
  • HY-111346
    1-Linoleoyl Glycerol Inhibitor
    1-Linoleoyl glycerol (1-LG) is a fatty acid glycerol that has been isolated from S. chinensis roots.
  • HY-100737
    ML349 Inhibitor 98.90%
    ML349 is a potent and specific acyl protein thioesterase 2 (APT-2) inhibitor with a Ki of 120 nM. ML349 is also an inhibitor of LYPLA2 with an IC50 of 144 nM.
  • HY-13735A
    Quinacrine dihydrochloride Inhibitor 98.00%
    Quinacrine is a fluorescent probe for the conformational transitions of the cholinergic receptor protein.
  • HY-10801
    CAY10650 Inhibitor >98.0%
    CAY10650 is a highly potent cytosolic phospholipase A2(alpha) (cPLA2(alpha)) inhibitor with an IC 50 value of 12 nM.
  • HY-N0134
    Tanshinone I Inhibitor >98.0%
    Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC50=11 μM) and rabbit recombinant cPLA2 (IC50=82 μM).
  • HY-B0653A
    Levobupivacaine hydrochloride Inhibitor 98.53%
    Levobupivacaine Hcl is a local anaesthetic compound belonging to the amino amide group; long-acting local anesthetic.
  • HY-100736
    ML348 Inhibitor 99.59%
    ML348 is a selective and reversible lysophospholipase 1 (LYPLA1) inhibitor (IC50 = 210 nM), Exhibits 14-fold selectivity for LYPLA1 over LYPLA2, Also selective over a panel of ~30 other serine hydrolases.
  • HY-P0233
    Melittin Activator
    Melittin is a PLA2 activator, stimulates the activity of the low molecular weight PLA2, while it does not the increase activity of the high molecular weight PLA2.
  • HY-18522
    AA26-9 Inhibitor 99.78%
    AA26-9 is a potent and broad spectrum serine hydrolase inhibitor.
  • HY-70083
    SPK-601 Inhibitor
    SPK-601(LMV-601) is a potent phosphatidylcholine-specific phospholipase C (PC-PLC) inhibitor; SPK-601 is useful antimicrobial agent.
  • HY-19757
    Lp-PLA2 -IN-1 Inhibitor 99.38%
    inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer(acute)s disease.
  • HY-17448
    Varespladib methyl Inhibitor
    Varespladib methyl is a selective inhibitor of group II secretory phospholipase A2 (PLA2).
  • HY-101579
    LY 178002 Antagonist
    LY 178002 is a potent inhibitor of cyclooxygenase, 5-1ipoxygenase, phospholipase A2 and cellular production of LTB4 by human polymorphonuclear leukocytes, with IC50 of 0.6 μM for 5-1ipoxygenase.
  • HY-U00037
    Ecopladib Inhibitor
    Ecopladib is a sub-micromolar inhibitor of cytosolic phospholipase A2α (cPLA2α), with IC50s of 0.15 μM and 0.11 μM in the GLU micelle and rat whole blood assays, respectively.